Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

BACKGROUND: Perioperative antiplatelet agents potentially increase bleeding after non–ST‐segment elevation (NSTE) acute coronary syndromes (ACS). The protease‐activated receptor 1 antagonist vorapaxar reduced cardiovascular events and was associated with increased bleeding versus placebo in NSTE ACS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: van Diepen, Sean, Tricoci, Pierluigi, Podder, Mohua, Westerhout, Cynthia M., Aylward, Philip E., Held, Claes, Van de Werf, Frans, Strony, John, Wallentin, Lars, Moliterno, David J., White, Harvey D., Mahaffey, Kenneth W., Harrington, Robert A., Armstrong, Paul W.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845287/
https://ncbi.nlm.nih.gov/pubmed/26672080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.002546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados